NLRP3 and Hepatic fibrosis: It is well documented that the activation of the NLRP3 inflammasome/IL-1β axis can lead to pyroptosis of HSC, thereby exacerbating liver injury and eventually leading to hepatic fibrosis (Kong et al., 2019; Xie et al., 2022).